A Response to "Letter to the Editor Regarding 'Dupilumab Versus Lebrikizumab Demonstrates Greater Likelihood of Achieving and Maintaining Improvements in Efficacy Outcomes Using a Placebo-Adjusted Indirect Treatment Comparison'". - Ständer, Sonja; Pinter, Andreas; Hougeir, Firas G.; Guyot, Patricia; Xu, Yingxin; Praestgaard, Amy H.; Freemantle, Nick; Rossi, Ana B.; Bégo‑Le‑Bagousse, Gaëlle; Wang, Zhixiao; Noonan, Kerry; Bastian, Mike (Dermatology & Therapy, 2026)